Adoption of DOAC population management tool dashboard before July 2018 linked to decline in off-label dosing prescriptions HealthDay News — Early adoption of the direct oral anticoagulant (DOAC) ...
The risk for death goes up for patients with atrial fibrillation (AF) who are put on direct oral anticoagulants (DOAC) at dosages other than those approved for stroke prevention, whether higher or ...
Credit: Getty Images. This registry-based cohort study aimed to assess both the frequency of prescription of concomitant aspirin (ASA) and DOAC therapy as well as its effect on clinical outcomes in ...
A new meta-analysis shows that Asians with atrial fibrillation experience better safety and efficacy outcomes on direct oral anticoagulants (DOACs) compared to warfarin. The findings could influence ...
In everyday practice, patients with atrial fibrillation or flutter who are newly started on apixaban (Eliquis; Bristol-Myers Squibb) have lower ischemic and bleeding risks compared with those started ...
Despite concerns about the potential bleeding risk, IV thrombolysis could be safely given to ischemic stroke patients within a day of direct oral anticoagulant (DOAC) therapy, according to ...
Among patients hospitalized for atrial fibrillation (AF) or flutter, prescription of an off-label dose of a direct oral anticoagulant (DOAC) at discharge remains relatively common, according to data ...
Study authors assessed the effectiveness and safety of DOACs compared with warfarin in patients with valvular atrial fibrillation. People with valvular atrial fibrillation (AF) who are new users of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients hospitalized with atrial fibrillation who ...
FREMONT, Calif., March 22, 2026 (GLOBE NEWSWIRE)-- CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today ...
The DOAC Dipstick (DOASENSE GmbH) is a single-use, point-of-care dipstick test that is used to detect direct oral anticoagulants (DOACs) in urine. The urine dipstick test detects DOACs (both factor Xa ...
Swedish cohort study shows 13% (95% CI, 2-22%) lower risk of kidney function decline or kidney failure and 12% (95% CI, 3-20%) lower risk of acute kidney injury with use of direct oral anticoagulants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results